BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Ulonivirine readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Ulonivirine\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05093972-1021@assetmemo.bio
DTSTAMP:20261121T005722Z
DTSTART;VALUE=DATE:20270629
DTEND;VALUE=DATE:20270630
SUMMARY:Ulonivirine: Phase 1 readout est. (NCT05093972)
DESCRIPTION:Ulonivirine\, phase 1.\nStudy: Ulonivirine (MK-8507) in Partici
 pants With Mild or Moderate Hepatic Impairment (MK-8507-014)\nEstimated pr
 imary completion: 29 June 2027. This is a ClinicalTrials.gov estimate\, no
 t a confirmed readout date\, and it can move.\nDrug page: https://assetmem
 o.bio/drug/ulonivirine#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT05093972
URL:https://assetmemo.bio/drug/ulonivirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06891066-1021@assetmemo.bio
DTSTAMP:20261121T005722Z
DTSTART;VALUE=DATE:20270810
DTEND;VALUE=DATE:20270811
SUMMARY:Ulonivirine: Phase 2 readout est. (NCT06891066)
DESCRIPTION:Ulonivirine\, phase 2\, HIV.\nStudy: A Study of Islatravir (ISL
 ) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adult
 s With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)\nEstimat
 ed primary completion: 10 August 2027. This is a ClinicalTrials.gov estima
 te\, not a confirmed readout date\, and it can move.\nDrug page: https://a
 ssetmemo.bio/drug/ulonivirine#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT06891066
URL:https://assetmemo.bio/drug/ulonivirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07266831-1021@assetmemo.bio
DTSTAMP:20261121T005722Z
DTSTART;VALUE=DATE:20290201
DTEND;VALUE=DATE:20290202
SUMMARY:Ulonivirine: Phase 2/3 readout est. (NCT07266831)
DESCRIPTION:Ulonivirine\, phase 2/3\, HIV.\nStudy: A Clinical Study of Isla
 travir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Bef
 ore (MK-8591B-062)\nEstimated primary completion: 1 February 2029. This is
  a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can
  move.\nDrug page: https://assetmemo.bio/drug/ulonivirine#upcoming-events\
 nRegistry record: https://clinicaltrials.gov/study/NCT07266831
URL:https://assetmemo.bio/drug/ulonivirine#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
